SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-15-039232
Filing Date
2015-02-09
Accepted
2015-02-09 16:34:33
Documents
1
Group Members
KCG AMERICAS LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d869046dsc13g.htm SC 13G 31570
  Complete submission text file 0001193125-15-039232.txt   33405
Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 813.864.2554
ACCENTIA BIOPHARMACEUTICALS INC (Subject) CIK: 0001310094 (see all company filings)

IRS No.: 000000000 | State of Incorp.: FL | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-81399 | Film No.: 15588985
SIC: 2834 Pharmaceutical Preparations

Mailing Address 545 WASHINGTON BLVD. JERSEY CITY NJ 07310
Business Address 545 WASHINGTON BLVD. JERSEY CITY NJ 07310 201-356-1390
KCG AMERICAS LLC (Filed by) CIK: 0001457716 (see all company filings)

IRS No.: 264219373 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G